Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer’s Disease at AD/PD 2026™
GlobeNewswire, Inc.
Pooled analyses in patients with moderate Alzheimer’s show dose-related cognitive benefit and signs of durability. 100% of patients remained stable or improved, with 50% improving from moderate to mild cognitive function.
Job Research Foundation Awards Grant to UNC Chapel Hill Doctor to Advance Research into Job Syndrome, a Rare Disorder
EIN Presswire
Since 2019, the Job Research Foundation has supported 17 scientific research projects worldwide investigating the rare disorder known as Job Syndrome.
From ideas to impact: TM Forum Excellence Awards recognize the industry leaders delivering real-world results
EIN Presswire
19th annual Excellence Awards celebrate telco innovation demonstrating measurable production impact across AI, autonomy and composable architectures.
TOMI Environmental Solutions’ Binary Ionization Technology Approved in the Netherlands
GlobeNewswire, Inc.
FREDERICK, Md., March 25, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced today that its Binary Ionization Technology has received...
spektr Launches spektrQ to Answer Compliance's Hardest AI Question: Where to Start
EIN Presswire
New embedded team brings compliance practitioners and AI specialists into every enterprise client relationship from day one. COPENHAGEN, DENMARK, June 24, 2026 /EINPresswire.com/ -- spektr, the AI compliance platform for financial services,...
Hearing Aids Market Size Worth USD 14.53 Billion by 2032, Exclusive Report by Maximize Market Research
EIN Presswire
The Hearing Aids Market was valued at USD 9.53 billion in 2025 and is projected to reach USD 14.53 billion by 2032, growing at a CAGR of 6.2%. ROCKVILLE , MD, UNITED STATES, March 25, 2026 /EINPresswire.com/ -- Maximize Market Research, the...
Alamar Biosciences Launches NULISAseq™ Neuro 220 Panel, its largest precision proteomics panel with the sensitivity and specificity to advance neurological disease research
GlobeNewswire, Inc.
New panel expands coverage for Alzheimer’s and Parkinson’s diseases including 15 new biomarkers developed with support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and 12 assays specific to brain and peripheral Tau isoforms...
Denmark Moves to Recognize Gastronomy as an Art Form
GlobeNewswire, Inc.
Copenhagen, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Today, at the global gastronomy symposium Convergence, Denmark’s Minister of Culture, Jakob Engel-Schmidt, announced that the Ministry of Culture will explore whether gastronomy can be formally...
Stem Cell Manufacturing Market to Reach USD 41.67 Billion by 2034, Growing at an 11.35% CAGR
GlobeNewswire, Inc.
Ottawa, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The global stem cell manufacturing market size is calculated at USD 17.63 billion in 2026 and is expected to reach around USD 41.67 billion by 2034, growing at a CAGR of 11.35% for the forecasted period....
CervoMed Announces New Data at the AD/PD™ 2026 Scientific Conference that Reinforce Neflamapimod’s Positive Effects in Dementia with Lewy Bodies (DLB) in Patients without Alzheimer’s Disease Co-Pathology
GlobeNewswire, Inc.
New analyses show DLB patients with lower plasma pTau181 levels — indicating an earlier stage of disease and absence of Alzheimer’s disease (AD) co-pathology — experienced greater clinical benefit with neflamapimod in Phase 2b clinical trial PK/PD...
![New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual…](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/2511067-531100496-amarin-logo-jpeg-jpg-100x20.jpeg){kind=logo}
New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual…
GlobeNewswire, Inc.
DUBLIN and BRIDGEWATER, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today announced that additional REDUCE-IT patient...
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery™, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026
GlobeNewswire, Inc.
NEWTON, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target soluble amyloid beta oligomers (AβOs) for the treatment of...
Critical Metals Corp Nasdaq-CRML Has Successfully Acquired a Strategic Arctic Ship Housing Asset Providing Long Term & Turn-Key Accommodations at Site for Up to 300 Workers at Tanbreez
GlobeNewswire, Inc.
NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, is pleased to announce the acquisition of the Ocean Endeavour, a 180-passenger...
Global Passport Index 2026: Europe Holds Its Ground as the World’s Mobility Gold Standard
EIN Presswire
Nine of the world’s ten strongest passports are European with the Schengen Area’s expansion to 29 states reinforcing unmatched structural mobility LONDON , UNITED KINGDOM, June 30, 2026 /EINPresswire.com/ -- Sub1: Nine of the world’s ten...
Siemens Healthineers Launches Brain Health Research Portfolio with First Biomarker Assays Now Available
GlobeNewswire, Inc.
Tarrytown, New York, USA, March 18, 2026 (GLOBE NEWSWIRE) -- Research assays help generate evidence about whether biomarkers can advance disease management Novel RUO tests can help scientists understand neurological function and disease...
Commit Biologics appoints serial biotech founder as new CEO to take complement-powered immune engagers into the clinic
GlobeNewswire, Inc.
Dr. Thomas L. F. Montgomery Andresen joins from T-Cypher Bio Follows breakthrough non-human primate data demonstrating deep B-cell depletion without cytokine release Commit is poised to nominate its first two clinical development candidates later...
Aalberts N.V.: Aalberts completes divestment Broen in Denmark
GlobeNewswire, Inc.
Utrecht, 12 March 2026 Aalberts N.V. announces the successful completion of regulatory approvals and closing conditions, finalising the divestment of BROEN A/S (Broen), headquartered in Denmark, generating an annual revenue of approximately EUR 82...
Biotechnology Market Size to Surpass USD 9.06 Trillion by 2035
GlobeNewswire, Inc.
Ottawa, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The global biotechnology market size is calculated at USD 2.45 trillion in 2025, grew to USD 2.79 trillion in 2026, and is projected to reach around USD 9.06 trillion by 2035. The market is projected to...
NKGen Biotech to Present Integrated Phase 1 Clinical and Biomarker Analyses for Troculeucel in Alzheimer’s Disease at AD/PD™ 2026
GlobeNewswire, Inc.
SANTA ANA, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic...
TM Forum reveals AI trust gap: 72% of CSPs say their AI is trustworthy, only 14% can prove it
EIN Presswire
TM Forum CEO, Nik Willetts, reveals trustworthy AI gap threatens the autonomous enterprise, in DTW Ignite 2026 keynote COPENHAGEN, DENMARK, June 23, 2026 /EINPresswire.com/ -- Delivering the opening keynote at DTW Ignite 2026, TM Forum CEO Nik...
Sign up for:
Technology Reporter Denmark
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.